Evolus Statistics
Total Valuation
Evolus has a market cap or net worth of GBP 455.94 million. The enterprise value is 502.27 million.
Market Cap | 455.94M |
Enterprise Value | 502.27M |
Important Dates
The next estimated earnings date is Monday, August 4, 2025.
Earnings Date | Aug 4, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 63.32M |
Shares Outstanding | n/a |
Shares Change (YoY) | +9.99% |
Shares Change (QoQ) | +0.52% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 54.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.14 |
PB Ratio | -89.20 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -11.55 |
EV / Sales | 2.45 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -26.43 |
Financial Position
The company has a current ratio of 2.34
Current Ratio | 2.34 |
Quick Ratio | 2.05 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -5.30 |
Interest Coverage | -1.78 |
Financial Efficiency
Return on equity (ROE) is -949.46% and return on invested capital (ROIC) is -15.31%.
Return on Equity (ROE) | -949.46% |
Return on Assets (ROA) | -9.36% |
Return on Invested Capital (ROIC) | -15.31% |
Return on Capital Employed (ROCE) | -20.95% |
Revenue Per Employee | 573,133 |
Profits Per Employee | -116,937 |
Employee Count | 332 |
Asset Turnover | 1.25 |
Inventory Turnover | 8.07 |
Taxes
In the past 12 months, Evolus has paid 533,279 in taxes.
Income Tax | 533,279 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.00% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +13.00% |
50-Day Moving Average | 12.29 |
200-Day Moving Average | 13.53 |
Relative Strength Index (RSI) | 65.90 |
Average Volume (20 Days) | 3,893 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 11.91 |
Income Statement
In the last 12 months, Evolus had revenue of GBP 213.21 million and -43.50 million in losses. Loss per share was -0.69.
Revenue | 213.21M |
Gross Profit | 145.86M |
Operating Income | -25.47M |
Pretax Income | -42.97M |
Net Income | -43.50M |
EBITDA | -21.25M |
EBIT | -25.47M |
Loss Per Share | -0.69 |
Balance Sheet
The company has 52.55 million in cash and 100.77 million in debt, giving a net cash position of -48.22 million.
Cash & Cash Equivalents | 52.55M |
Total Debt | 100.77M |
Net Cash | -48.22M |
Net Cash Per Share | n/a |
Equity (Book Value) | -5.11M |
Book Value Per Share | -0.08 |
Working Capital | 58.42M |
Cash Flow
In the last 12 months, operating cash flow was -17.81 million and capital expenditures -1.19 million, giving a free cash flow of -19.00 million.
Operating Cash Flow | -17.81M |
Capital Expenditures | -1.19M |
Free Cash Flow | -19.00M |
FCF Per Share | n/a |
Margins
Gross margin is 68.41%, with operating and profit margins of -11.95% and -20.40%.
Gross Margin | 68.41% |
Operating Margin | -11.95% |
Pretax Margin | -20.15% |
Profit Margin | -20.40% |
EBITDA Margin | -9.97% |
EBIT Margin | -11.95% |
FCF Margin | n/a |
Dividends & Yields
Evolus does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.99% |
Shareholder Yield | n/a |
Earnings Yield | -9.54% |
FCF Yield | -4.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Evolus has an Altman Z-Score of -0.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.62 |
Piotroski F-Score | 3 |